Literature DB >> 9262998

A methodology for specifying PET VOI's using multimodality techniques.

G J Klein1, X Teng, W J Jagust, J L Eberling, A Acharya, B W Reutter, R H Huesman.   

Abstract

Volume-of-interest (VOI) extraction for radionuclide and anatomical measurements requires correct identification and delineation of the anatomical feature being studied. We have developed a toolset for specifying three-dimensional (3-D) VOI's on a multislice positron emission tomography (PET) dataset. The software is particularly suited for specifying cerebral cortex VOI's which represent a particular gyrus or deep brain structure. A registered 3-D magnetic resonance image (MRI) dataset is used to provide high-resolution anatomical information, both as oblique two-dimensional (2-D) sections and as volume renderings of a segmented cortical surface. VOI's are specified indirectly in two dimensions by drawing a stack of 2-D regions on the MRI data. The regions are tiled together to form closed triangular mesh surface models, which are subsequently transformed into the observation space of the PET scanner. Quantification by this method allows calculation of radionuclide activity in the VOI's, as well as their statistical uncertainties and correlations. The methodology for this type of analysis and validation results are presented.

Mesh:

Year:  1997        PMID: 9262998     DOI: 10.1109/42.611350

Source DB:  PubMed          Journal:  IEEE Trans Med Imaging        ISSN: 0278-0062            Impact factor:   10.048


  8 in total

1.  Memory failure has different mechanisms in subcortical stroke and Alzheimer's disease.

Authors:  B R Reed; J L Eberling; D Mungas; M W Weiner; W J Jagust
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

2.  Effects of subcortical cerebral infarction on cortical glucose metabolism and cognitive function.

Authors:  L T Kwan; B R Reed; J L Eberling; N Schuff; J Tanabe; D Norman; M W Weiner; W J Jagust
Journal:  Arch Neurol       Date:  1999-07

3.  Cognition, glucose metabolism and amyloid burden in Alzheimer's disease.

Authors:  Ansgar J Furst; Gil D Rabinovici; Ara H Rostomian; Tyler Steed; Adi Alkalay; Caroline Racine; Bruce L Miller; William J Jagust
Journal:  Neurobiol Aging       Date:  2010-04-24       Impact factor: 4.673

4.  Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.

Authors:  Gil D Rabinovici; William J Jagust; Ansgar J Furst; Jennifer M Ogar; Caroline A Racine; Elizabeth C Mormino; James P O'Neil; Rayhan A Lal; Nina F Dronkers; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

5.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Authors:  Gil D Rabinovici; Ansgar J Furst; Adi Alkalay; Caroline A Racine; James P O'Neil; Mustafa Janabi; Suzanne L Baker; Neha Agarwal; Stephen J Bonasera; Elizabeth C Mormino; Michael W Weiner; Maria L Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

6.  White matter lesions impair frontal lobe function regardless of their location.

Authors:  M Tullberg; E Fletcher; C DeCarli; D Mungas; B R Reed; D J Harvey; M W Weiner; H C Chui; W J Jagust
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

7.  Striatal dopamine and working memory.

Authors:  Susan M Landau; Rayhan Lal; James P O'Neil; Suzanne Baker; William J Jagust
Journal:  Cereb Cortex       Date:  2008-06-11       Impact factor: 5.357

8.  Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration.

Authors:  Roshan Cools; Michael J Frank; Sasha E Gibbs; Asako Miyakawa; William Jagust; Mark D'Esposito
Journal:  J Neurosci       Date:  2009-02-04       Impact factor: 6.167

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.